Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy

References

• Liu L, Xie H, Mu L, et al. Functional chlorin gold nanorods enable to treat breast cancer by photothermal/photodynamic therapy. Int J Nanomedicine. 2018;13:8119–8135. doi:10.2147/IJN.S18697430555230
   PubMed Web of Science ®Google Scholar
• Wu P, Lin C, Lin C, et al. Methylene-blue-encapsulated liposomes as photodynamic therapy nano agents for breast cancer cells. Nanomaterials. 2019;9(1):14–25. doi:10.3390/nano9010014
   Web of Science ®Google Scholar
• Doix B, Bastien E, Rambaud A, et al. Preclinical evaluation of white led-activated non-porphyrinic photosensitizer OR141 in 3D tumor spheroids and mouse skin lesions. Front Oncol. 2018;8:393. doi:10.3389/fonc.2018.0039330298119
   PubMedGoogle Scholar
• Nackiewicz J, Kliber-Jasik M, Skonieczna M. A novel pro-apoptotic role of zinc octacarboxyphthalocyanine in melanoma me45 cancer cell’s photodynamic therapy (PDT). J Photochem Photobio B. 2019;190:146–153. doi:10.1016/j.jphotobiol.2018.12.002
   PubMed Web of Science ®Google Scholar
• Halaburková A, Jendželovský R, Kovaľ J, et al. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A. Clin Epigenet. 2017;9(1):62–77. doi:10.1186/s13148-017-0359-x
   PubMedGoogle Scholar
• Li P, Tsai Y, Lee M, et al. Increased histone deacetylase activity involved in the suppressed invasion of cancer cells survived from ALA-mediated photodynamic treatment. Int J Mol Sci. 2015;16(10):23994–24010. doi:10.3390/ijms16102399426473836
   PubMedGoogle Scholar
• Zakaria S, Gamal-Eldeen AM, El-Daly SM, et al. Synergistic apoptotic effect of Doxil® and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells. Photodiagn Photodyn. 2014;11(2):227–238. doi:10.1016/j.pdpdt.2014.03.001
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu Y, Wu Z, et al. Latent role of in vitro Pb exposure in blocking A β-clearance and triggering epigenetic modifications. Environ Toxicol Phar. 2019;66:14–23. doi:10.1016/j.etap.2018.12.015
   PubMed Web of Science ®Google Scholar
• Andrew J, Katherine M, Ruchi P, et al. Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor models. Exp Cell Res. 2019;375(2):106–112. doi:10.1016/j.yexcr.2018.12.01230579954
   PubMedGoogle Scholar
• Lewis K, Jordan H, Tollefsbol T. Effects of SAHA and EGCG on growth potentiation of triple-negative breast cancer cells. Cancers. 2019;11(1):23–44. doi:10.3390/cancers11010023
   Web of Science ®Google Scholar
• Zhang F, Chen Z, Shao C, et al. Is level of acetylation directly correlated to radiation sensitivity of cancer cell? Mutat Res Fund Mol Mech Mutagen. 2019;813:13–19. doi:10.1016/j.mrfmmm.2018.11.001
   PubMed Web of Science ®Google Scholar
• Groselj B, Sharma NL, Hamdy FC, et al. Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair. Br J Cancer. 2013;108:748–754. doi:10.1038/bjc.2013.2123361058
   PubMed Web of Science ®Google Scholar
• Babu A, Kamaraj M, Basu M, et al. Chemical and genetic rescue of an ep300 knockdown model for rubinstein taybi syndrome in zebrafish. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4):1203–1215. doi:10.1016/j.bbadis.2018.01.02929409755
   PubMedGoogle Scholar
• Li Y, Seto E. HDACs and HDAC Inhibitors in cancer development and therapy. Csh Perspect Med. 2016;6(10):1–24.
   Google Scholar
• Bahhaj FE, Denis I, Pichavant L, et al. Histone deacetylase inhibitors delivery using nanoparticles with intrinsic passive tumor targeting properties for tumor therapy. Theranostics. 2016;6(6):795–807. doi:10.7150/thno.1372527162550
   PubMedGoogle Scholar
• Zeng S, Xiong MP. Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1). Biomaterials. 2013;34(28):6882–6892. doi:10.1016/j.biomaterials.2013.05.01023768780
   PubMed Web of Science ®Google Scholar
• He J, Duan S, Yu X, et al. Folate-modified chitosan nanoparticles containing the IP-10 gene enhance melanoma-specific cytotoxic CD8(+)CD28(+) T lymphocyte responses. Theranostics. 2016;6:752–761. doi:10.7150/thno.1452727022421
   PubMedGoogle Scholar
• Kang JH, Battogtokh G, Ko YT. Folate-targeted liposome encapsulating chitosan/oligonucleotide polyplexes for tumor targeting. AAPS PharmSciTech. 2014;15:1087–1092. doi:10.1208/s12249-014-0136-524848761
   PubMed Web of Science ®Google Scholar
• Wang H, Sheng W. (131)I-traced PLGA-lipid nanoparticles as drug delivery carriers for the targeted chemotherapeutic treatment of melanoma. Nanoscale Res Lett. 2017;12:365. doi:10.1186/s11671-017-2140-728532129
   PubMedGoogle Scholar
• Jin M, Jin G, Kang L, et al. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. Int J Nanomedicine. 2018;13:2405–2426. doi:10.2147/IJN.S16142629719390
   PubMed Web of Science ®Google Scholar
• Niu K, Yao Y, Xiu M, et al. Controlled drug delivery by polylactide stereocomplex micelle for cervical cancer chemotherapy. Front Pharmacol. 2018;9:930. doi:10.3389/fphar.2018.0093030154721
   PubMedGoogle Scholar
• Raucher D, Dragojevic S, Ryu J. Macromolecular drug carriers for targeted glioblastoma therapy: preclinical studies, challenges, and future perspectives. Front Oncol. 2018;8:624. doi:10.3389/fonc.2018.0062430619758
   PubMedGoogle Scholar
• Zhang B, Hu Y, Pang Z. Modulating the tumor microenvironment to enhance tumor nanomedicine delivery. Front Pharmacol. 2017;8:952. doi:10.3389/fphar.2017.0095229311946
   PubMed Web of Science ®Google Scholar
• Liu L, Chen B, Qin S, et al. A novel histone deacetylase inhibitor chidamide induces apoptosis of human colon cancer cells. Biochem Bioph Res Co. 2010;392(2):190–195. doi:10.1016/j.bbrc.2010.01.011
   PubMed Web of Science ®Google Scholar
• Lai TC, Kataoka K, Kwon GS. Bioreducible polyether-based pDNA ternary polyplexes: balancing particle stability and transfection efficiency. Colloids Surf B. 2012;99:27–37. doi:10.1016/j.colsurfb.2011.09.026
   PubMed Web of Science ®Google Scholar
• Ke Z, Yang L, Wu H, et al. Evaluation of in vitro and in vivo antitumor effects of gambogic acid-loaded layer-by-layer self-assembled micelles. Int J Pharmaceut. 2018;545(1–2):306–317. doi:10.1016/j.ijpharm.2018.04.016
   PubMed Web of Science ®Google Scholar
• Ning Z, Li Z, Newman MJ, et al. Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity. Cancer Chemoth Pharm. 2012;69(4):901–909. doi:10.1007/s00280-011-1766-x
   PubMed Web of Science ®Google Scholar
• Cai X, Liu B, Pang M, et al. Interfacially synthesized Fe-soc-MOF nanoparticles combined with ICG for photothermal/photodynamic therapy. Dalton Trans. 2018;47:16329–16365. doi:10.1039/c8dt02941e30403239
   PubMedGoogle Scholar
• Deng Y, Jia F, Chen S, et al. Nitric oxide as an all-rounder for enhanced photodynamic therapy: hypoxia relief, glutathione depletion and reactive nitrogen species generation. Biomaterials. 2018;187:55–65. doi:10.1016/j.biomaterials.2018.09.04330292942
   PubMedGoogle Scholar
• Wei Y, Wei Z, Luo P, et al. pH-sensitive metal-phenolic network capsules for targeted photodynamic therapy against cancer cells. Artif Cells Nanomed Biotechnol. 2018;46:1552–1558. doi:10.1080/21691401.2017.137772428918670
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang X, Cheng W, et al. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription. Retrovirology. 2019;16:5–27. doi:10.1186/s12977-019-0467-030782173
   PubMedGoogle Scholar
• Vantieghem A, Xu Y, Assefa Z, et al. Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis. J Biol Chem. 2002;277:37718–37731. doi:10.1074/jbc.M20434820012101183
   PubMed Web of Science ®Google Scholar
• Eva Bernhart NS, Kaltenegger H, Windpassinger C, et al. Histone deacetylase inhibitors vorinostat and panobinostatinduce G1 cell cycle arrest and apoptosis in multidrug resistantsarcoma cell lines. Oncotarget. 2017;8(44):77254–77267. doi:10.18632/oncotarget.2046029100385
   PubMedGoogle Scholar
• Qian H. Antitumor activity of Chidamide in hepatocellular carcinoma cell lines. Mol Med Rep. 2012;5:1503–1508. doi:10.3892/mmr.2012.85822484326
   PubMedGoogle Scholar